Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Corbus Pharmaceuticals Q4 EPS $(2.61) Misses $(2.10) Estimate

Corbus Pharmaceuticals (NASDAQ:CRBP) reported quarterly losses of $(2.61) per share which missed the analyst consensus estimate of $(2.10) by 24.29 percent. This is a 8.75 percent decrease over losses of $(2.40) per

byBenzinga Newsdesk

March 7, 2023

1 minute read

Corbus Pharmaceuticals (NASDAQ:CRBP) reported quarterly losses of $(2.61) per share which missed the analyst consensus estimate of $(2.10) by 24.29 percent. This is a 8.75 percent decrease over losses of $(2.40) per share from the same period last year.